US Patent 8476308 GPR120 receptor agonists and uses thereof
Patent 8476308 was granted and assigned to Metabolex on July, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Nov, 2023
Golden AI
Edits made to:
Article (+191 characters)
Article
Patent abstract
GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.
Edits on 22 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Aaron Novack0
Christopher J. Rabbat0
Dong Fang Shi0
Imad Fayek Nashashibi0
Jiangao Song0
Jingyuan Ma0
Phuongly Pham0
Xin Chen0
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08476308 GPR120 receptor agonists and uses thereof US Patent 8476308 GPR120 receptor agonists and uses thereof
Infobox
Patent Number
084763080
Patent Number
84763080
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
084763080
Date of Patent
July 2, 2013
0Patent Application Number
136452870
Date Filed
October 4, 2012
0Patent Primary Examiner
Edits on 17 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 08476308 GPR120 receptor agonists and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
08476308
Date of patent
July 2, 2013
Patent application number
13645287
Date Filed
October 4, 2012
Patent primary examiner
Find more entities like US Patent 8476308 GPR120 receptor agonists and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
